the primary targets of FIV in its feline host [3] , also represented the principal primate cell type infected in vivo. Moreover, the severity of the CD4ϩ cell depletion observed in FIV-infected macaques indicated that FIV infection was highly toxic to select primate cells in vivo.
For the confirmation of the in vivo infection of primate cells by FIV, the presence of the FIV pol gene in blood and tissue was assessed by nested PCR and RT-PCR amplification of genomic DNA and total cellular RNA, respectively, with the primers and conditions described previously [2] . Although FIV was not detectable in either macaque prior to infection (week 0), FIV-specific sequences were detected in PBMC from CM1SP until 9 weeks and in CM2ST until 4 weeks (Figure 2a) . Similarly, RT-PCR revealed the presence of FIV RNA in sera collected from each animal over the same period, although viral sequences were only detectable for 4 weeks in CM1SP and 2 weeks in CM2ST ( Figure 2a ). An analysis of necropsied tissue from each macaque demonstrated that FIV sequences were also present in RNA and DNA isolated from spleen from CM1SP and in RNA from both lymph node and spleen tissue from CM2ST, but not in any other tissues investigated ( Figure 2b ). It is unlikely that these results represented residual cells from the initial transfusion of infected PBMC. Animals were transfused with only 4 ϫ 10 6 cells, of which approximately 10% were infected [2] , and the cytotoxicity associated with FIV infection would have reduced this number further. In addition, the abundance of viral DNA detected in PBMC varied over the time course, and this variation indicates changes in the number of infected cells.
FIV infection is associated with weight loss and depletion of CD4ϩ cells. Cynomolgus macaques were infected with FIV, body weight was
The above findings extended earlier in vitro results by measured, and blood, from which mononuclear cells were isolated, demonstrating that FIV could infect nonhuman primate was harvested at successive weeks PI. The same parameters were cells in vivo and induce symptoms characteristic of FIV assessed for 6 weeks before infection. CM2ST received intramuscular injections of tetanus toxoid (0.25 ml) at weeks 9 and 10 PI (arrows), infection. However, differences were observed between while CM1SP remained untreated after the initial infection. than CM2ST (Figure 2) , and this result suggests that Cells incubated either in the absence of antibodies or with 1 g/ml of isotype-matched murine IgG 1 served as controls for each animal.
CM2ST was able either to clear the virus or to control
A marked decline in CD4ϩ cells exceeded 70% and was detected the infection more efficiently. Since latent infection of in both animals.
primate cells has been observed in vitro [12] , the question of viral persistence was addressed by the stimulation of PBMC isolated from each macaque with phorbol-12-myristate-13-acetate (PMA; Sigma, Oakville, Ontario, 1b). No change in the level of CD8ϩ cells was observed for CM2ST, but CD4ϩ levels decreased by 76.5% within Canada). Like primate lentivirus genomes, the Petaluma genome contains promoter elements that bind phorbol the first 3 weeks PI (Figure 1b) . Compared to preinfection values, monocyte and neutrophil levels were decreased ester-activated transcription factors, such as members of the activated protein (AP)-1 family [13] . Although FIV by 10% and 5%, respectively, after infection in both macaques, but the abundance of these cells did not vary over was not detectable by RT-PCR analysis of PBMC harvested from CM2ST at week 6 PI, viral RNA ( Figure 2c ) the time course. These results suggested that CD4ϩ cells, and elevated RT activity (not shown) were detected in cultures of these cells after stimulation with PMA. Similar results were observed with PBMC obtained from CM1SP at week 12 PI (Figure 2c ) and suggest that latently infected cells persisted in both animals. To investigate this hypothesis in vivo, CM2ST was immunized at weeks 9 and 10 PI with tetanus toxoid (TTX; Connaught Labs, Seattle, Washington), a compound shown previously to activate lentiviral replication in latently infected cells [14] . Following treatment with TTX, weight loss was observed again in CM2ST and had decreased approximately 10% by week 12 PI (Figure 1a) . Although a similar decline in CD4ϩ cells was not detected in these cells, the increase that had been observed from week 3 to week 9 was arrested ( Figure 1b) . Moreover, FIV genome, which was not detectable in either PBMC or serum beyond 4 weeks PI before CM2ST was immunized, was again detected at week 12 ( Figure 3a) . These results indicate that FIV persisted in immunocompetent primate hosts at levels below the limit of detection of the PCR protocol (approximately 10 copies [2]) for a minimum of 3 months after initial exposure to the virus. Moreover, an activating stimulus could induce further replication and spread of the virus.
Because numerous host factors, such as virus-specific immune responses, influence the persistence of lentiviruses in vivo, the production of anti-FIV antibodies by infected macaques was investigated by Western blot analysis [15] . Using sera collected from CM2ST at weeks 6 and 12 PI as sources of antibodies, we detected prominent bands at 25 kDa and 55 kDa in protein extracts derived from the blood of a Petaluma-infected adult cat, with additional bands observed at higher molecular weights (Figure 3b  and 3c) . Similar bands were detectable in protein extracts Detection of FIV-specific sequences in infected macaques.
from DH5␣ bacteria expressing Petaluma gag-encoded pro-
Necropsied tissue, PBMC, and sera were harvested from FIVteins but not in protein isolated from untransformed infected macaques, and genomic DNA and total RNA, from which cDNA was prepared, were isolated. The presence of viral sequences (Figure 3d ). These findings suggest that antibodies up to 9 weeks in PBMC and 4 weeks in serum isolated from CM1SP.
against the FIV p25 capsid protein and the p55 Gag poly-FIV sequences were detected for up to 4 weeks in PBMC and 2 protein were present in serum from CM2ST. No immuweeks in serum isolated from CM2ST. After treatment with tetanus noreactivity was detected with serum collected from toxoid at weeks 9 and 10 PI, viral sequences were again found in CM2ST before infection (Figure 3a) or from CM1SP at ability of macaques infected with simian-human immunoto suggest that FIV represents a health hazard. For example, the design of the current study circumvents many of deficiency viruses (SHIV) to develop a detectable antibody response against the virus, whereas a marked but the natural barriers to cross-species infection by FIV, while the small number of animals used makes definitive transient decrease in CD4ϩ cells still allows for rapid seroconversion [9, 16] . However, only antibodies to FIV conclusions about the properties of FIV infection of primate cells difficult. However, in the context of xenotransgag-encoded proteins were investigated in the present study, and it is conceivable that antibodies to other FIV plantation and gene therapy based on viral vectors, the transmission barriers between animal viruses and humans antigens were present in sera from CM1SP. In addition, seroconversion may have been observed if the infection are also greatly reduced due to immunosuppressive therapies designed to prevent rejection of the foreign tissue had been followed beyond 12 weeks or the animal had been treated with tetanus toxoid, which would stimulate or adverse immune responses to the vector [6] . Thus, FIV may provide a model for assessing the mechanisms by FIV replication.
which lentivirus xenoinfections emerge. The abundance of studies demonstrating the capacity of viruses to cross species raises questions about ongoing
